MYL

Mylan Inc. News Headlines

$57
*  
0.51
0.89%
Get MYL Alerts
*Delayed - data as of Dec. 22, 2014  -  Find a broker to begin trading MYL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Orphan Drug Status for Teva/Xenon Drug - Analyst Blog
4/26/2013 3:22:50 PM - Zacks.com


After Hours Most Active for Apr 25, 2013 : ORI, PLD, MO, MSFT, DAL, JCP, GM, NTAP, MU, MYL, QQQ, AMZN
4/25/2013 3:44:56 PM - NASDAQ.com News


Mylan Shows Great Potential For Growth
4/22/2013 11:22:00 PM - Seeking Alpha


Favorable Court Ruling for Actavis - Analyst Blog
4/19/2013 5:13:27 PM - Zacks.com


Data on Teva's Milprosa - Analyst Blog
4/18/2013 6:13:34 PM - Zacks.com


Teva More Undervalued Than Mylan, Looks Towards Technology
4/18/2013 5:56:00 AM - Seeking Alpha


Still Neutral on Mylan - Analyst Blog
4/15/2013 5:20:01 PM - Zacks.com


Good News for Warner Chilcott - Analyst Blog
4/15/2013 4:50:01 PM - Zacks.com


Actavis Settles with Valeant - Analyst Blog
4/11/2013 12:09:46 PM - Zacks.com


TRO on Actavis Sale of Generic Pulmicort Respules - Analyst Blog
4/10/2013 9:50:01 AM - Zacks.com


Valeant Inks Deal with Actavis - Analyst Blog
4/8/2013 4:07:27 PM - Zacks.com


Can Teva's Short-Term Pressure Be Justified?
4/5/2013 3:05:00 PM - Seeking Alpha


Setback for Valeant Pharma - Analyst Blog
4/5/2013 12:09:47 PM - Zacks.com


Dr. Reddy's Launches Generic Reclast - Analyst Blog
4/4/2013 6:06:11 PM - Zacks.com


Another Generic Launch at Mylan - Analyst Blog
4/4/2013 2:09:14 PM - Zacks.com


Teva's Quartette Approved in the US - Analyst Blog
4/4/2013 9:08:29 AM - Zacks.com


KaloBios Pharma Incurs Wider Loss - Analyst Blog
4/3/2013 12:22:08 PM - Zacks.com


Perrigo Touches 52-Week High - Analyst Blog
4/3/2013 8:23:05 AM - Zacks.com


Perrigo Buys Velcera - Analyst Blog
4/2/2013 4:24:35 PM - Zacks.com


Dr. Reddy's Launches Generic Accutane - Analyst Blog
4/1/2013 4:11:48 PM - Zacks.com


Actavis/AZN Settle Crestor Litigation - Analyst Blog
3/26/2013 3:24:45 PM - Zacks.com


Data on Teva's Azilect - Analyst Blog
3/25/2013 6:26:35 PM - Zacks.com


Back to Neutral on Warner Chilcott - Analyst Blog
3/21/2013 1:32:22 PM - Zacks.com


Good News for Mylan's Generic Unit - Analyst Blog
3/20/2013 12:46:54 PM - Zacks.com


Mylan Settles Patent Dispute - Analyst Blog
3/14/2013 1:13:18 PM - Zacks.com